Integrum
22.6
SEK
-1.74 %
INTEG B
First North Stockholm
Medical Equipment & Services
Health Care
1 following
-1.74%
0%
-16.61%
-53.4%
-58.91%
-50.49%
-42.05%
-74.86%
+181.8%
+11.99%
integrum.se
Integrum is a medical technology company. The company is developing systems for skeletal anchored prostheses based on the developed OPRA implant system, which later are being resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of many patients with amputation. The company was founded in 1998 and is headquartered in Mölndal.
Revenue
104.12M
EBIT %
6.25 %
P/E
98.26
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
INTEG B
Daily low / high price
22.3 / 23.5
SEK
Market cap
438.37M SEK
Turnover
377.91K SEK
Volume
16K
Financial calendar
Interim report
2024-12-04
Interim report
2025-03-03
Annual report
2025-06-03
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Rickard Brånemark | 33.2 % | 49.1 % |
Nordnet Pensionförsäkring | 8.1 % | 6.2 % |
Försäkringsaktiebolaget, Avanza Pension | 7.7 % | 5.9 % |
Fiducian Tech FD | 4.1 % | 3.1 % |
State Street Bank and Trust | 3.2 % | 2.5 % |
Stena Finans AB | 2.4 % | 1.9 % |
Swedbank Robur Fonder | 2.4 % | 1.9 % |
Henrik Hedlund | 1.8 % | 1.4 % |
Henrik Dahlback | 1.7 % | 1.0 % |
Nolsterby Invest AB | 1.4 % | 1.0 % |
ShowingAll content types
Carnegie Commissioned Research: Integrum: Sales likely to pick up later this year – Q2 preview
Integrum AB: Ty Hanners utsedd till försäljningschef i USA med fokus på OPRA-implantatsystem för amputerade
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools